← Screener

RMDResMed

Health care · Medical Instruments · NYSE, OTC

Compare with peers → Embed

Filings with the SEC since Oct 30, 2018

1,005 filings, 5 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Aug 13, 2026

10-K, period to Jun 30, 2026

Latest quarterly reportOpen ↗

Oct 30, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Oct 29, 2026

8-K: Quarterly results, Other events

Filed in the last 30 days

of 1,005 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 24 events

Oct 30, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 29, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Sep 1, 20268-K Other events 8-K item 8.01
Aug 17, 2026Auditor Auditor change, Director or officer change, Regulation FD disclosure 8-K items 4.01, 5.02, 7.01
Aug 13, 202610-K Annual report (10-K) period ended Jun 30, 2026
Aug 6, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Jul 7, 20268-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
May 1, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Apr 30, 2026Officer CFO and CAO change (the “Company”) announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.
Apr 30, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Jan 30, 202610-Q Quarterly report (10-Q) period ended Dec 31, 2025
Jan 29, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Nov 20, 20258-K Director or officer change, Shareholder vote results 8-K items 5.02, 5.07
Oct 31, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 30, 20258-K Quarterly results, Other events 8-K items 2.02, 8.01
Aug 18, 20258-K Director or officer change 8-K item 5.02
Aug 8, 202510-K Annual report (10-K) period ended Jun 30, 2025
Aug 1, 20258-K Director or officer change 8-K item 5.02
Jul 31, 20258-K Quarterly results, Other events 8-K items 2.02, 8.01
Apr 24, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 23, 20258-K Quarterly results, Other events 8-K items 2.02, 8.01
Jan 31, 202510-Q Quarterly report (10-Q) period ended Dec 31, 2024
Jan 30, 20258-K Quarterly results, Other events 8-K items 2.02, 8.01
Nov 21, 20248-K Shareholder vote results 8-K item 5.07

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1005 Annual & quarterly 34 Current reports (8-K) 66 Insiders 840 Proxy & votes 17 Big owners (13D/13G) 27 Shares & debt offered 4 SEC letters 3 Other 14

Filed	Form	What it is	Period
Oct 1, 2026	DEFA14A	Extra proxy material		all files
Oct 1, 2026	DEF 14A	Proxy statement	Jun 30, 2026	all files
Oct 2, 2025	DEFA14A	Extra proxy material		all files
Oct 2, 2025	DEF 14A	Proxy statement	Jun 30, 2025	all files
Oct 25, 2024	DEFA14A	Extra proxy material		all files
Oct 3, 2024	DEFA14A	Extra proxy material		all files
Oct 3, 2024	DEF 14A	Proxy statement	Jun 30, 2024	all files
Oct 5, 2023	DEFA14A	Extra proxy material		all files
Oct 5, 2023	DEF 14A	Proxy statement	Jun 30, 2023	all files
Oct 5, 2022	DEFA14A	Extra proxy material		all files
Oct 5, 2022	DEF 14A	Proxy statement	Oct 5, 2022	all files
Oct 6, 2021	DEFA14A	Extra proxy material		all files
Oct 6, 2021	DEF 14A	Proxy statement	Oct 6, 2021	all files
Oct 6, 2020	DEFA14A	Extra proxy material		all files
Oct 6, 2020	DEF 14A	Proxy statement	Oct 6, 2020	all files
Oct 8, 2019	DEFA14A	Extra proxy material		all files
Oct 8, 2019	DEF 14A	Proxy statement	Nov 21, 2019	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →